C12N 15/69
Increasing the copy number of the vector
C12N15/69 (Increasing the copy number of the vector) appears on 122 US grants and 111 published applications in this corpus.
Search patents in C12N- Granted patents
- 122
- Published applications
- 111
- Assignees
- 111
- Inventors
- 353
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 5 | 0 |
| 1988 | 4 | 0 |
| 1989 | 4 | 0 |
| 1990 | 7 | 0 |
| 1991 | 2 | 0 |
| 1992 | 12 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 4 | 0 |
| 1996 | 6 | 0 |
| 1997 | 5 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 3 | 0 |
| 2001 | 2 | 1 |
| 2002 | 1 | 5 |
| 2003 | 2 | 5 |
| 2004 | 3 | 11 |
| 2005 | 2 | 5 |
| 2006 | 3 | 2 |
| 2007 | 5 | 6 |
| 2008 | 3 | 3 |
| 2009 | 1 | 9 |
| 2010 | 3 | 6 |
| 2011 | 6 | 2 |
| 2012 | 2 | 4 |
| 2013 | 4 | 2 |
| 2014 | 0 | 2 |
| 2015 | 5 | 4 |
| 2016 | 1 | 4 |
| 2017 | 2 | 2 |
| 2018 | 4 | 3 |
| 2019 | 1 | 6 |
| 2020 | 0 | 5 |
| 2021 | 3 | 6 |
| 2022 | 0 | 3 |
| 2023 | 2 | 7 |
| 2024 | 4 | 4 |
| 2025 | 3 | 4 |
| 2026 | 2 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Univariant extrinsic initiator control system for microbes and an in vitro assembly of large recombinant DNA molecules from multiple components2 Jun 2026US 12,644,126 B2Massachusetts Institute of Technology
- Recombinant yeast strain having sterol productivity, preparation method therefor and use thereof10 Mar 2026US 12,570,991 B2Chung Ang University Industry Academic Cooperation Foundation
- Method for improving retroviral transduction and gene editing in hematopoietic stem cells using clyclosporin H and UM1712 Dec 2025US 12,485,187 B2Fondazione Telethon
- Synthetic self-amplifying MRNA molecules with secretion antigen and immunomodulator16 Sep 2025US 12,416,032 B2SunVax mRNA Therapeutics Inc.
- Method for quantitatively controlling plasmid copy number in antibiotic-free plasmid maintenance system11 Mar 2025US 12,247,242 B2Postech Academy-Industry Foundation
- Bioconversion of levulinic acid in genetically engineered hosts22 May 2025US 2025/0163478 A1Wisconsin Alumni Research Foundation
- Functional DNA Cassette and Plasmid27 Feb 2025US 2025/0066800 A1Moderna Enzymatics Co., Ltd.
- Modified viral capsids13 Feb 2025US 2025/0051396 A1
- Markerless dna production9 Jan 2025US 2025/0011798 A1ModernaTX, Inc.
- Synthetic self-amplifying mrna molecules with secretion antigen and immunomodulator28 Nov 2024US 2024/0392339 A1SunVax mRNA Therapeutics Inc.
Most cited
By later US patents
- Genetic constructs for delaying or repressing the expression of a target gene369US 6,573,099 B2Benitec Australia Limited · 2003
- Selective amplification of target polynucleotide sequences212US 5,437,990 AThe Board of Trustees of the Leland Stanford Junior University · 1995
- Selective amplification of target polynucleotide sequences140US 6,410,276 B1The Board of Trustees of the Leland Stanford Junior University · 2002
- Methods and compositions for amplifying DNA clone copy number135US 7,138,267 B1Epicentre Technologies Corporation · 2006
- High throughput DNA sequencing vector108US 6,258,571 B1Genset S.A. · 2001